The National Institute for Health and Clinical Excellence (NICE) has issued draft guidelines recommending a drug-infused eye implant for some patients that suffer from vision loss caused by macular oedema. The findings, which were praised by the Royal National Institute of Blind People (RNIB), could benefit patients who have problems with diabetic retinopathy and central retinal vein occlusion....
Click (here) for the complete story.
Wednesday, June 8, 2011
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment